252 related articles for article (PubMed ID: 11384870)
1. Vitamin D and prostate cancer.
Tuohimaa P; Lyakhovich A; Aksenov N; Pennanen P; Syvälä H; Lou YR; Ahonen M; Hasan T; Pasanen P; Bläuer M; Manninen T; Miettinen S; Vilja P; Ylikomi T
J Steroid Biochem Mol Biol; 2001; 76(1-5):125-34. PubMed ID: 11384870
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).
Ahonen MH; Tenkanen L; Teppo L; Hakama M; Tuohimaa P
Cancer Causes Control; 2000 Oct; 11(9):847-52. PubMed ID: 11075874
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract.
Blomberg Jensen M; Nielsen JE; Jørgensen A; Rajpert-De Meyts E; Kristensen DM; Jørgensen N; Skakkebaek NE; Juul A; Leffers H
Hum Reprod; 2010 May; 25(5):1303-11. PubMed ID: 20172873
[TBL] [Abstract][Full Text] [Related]
4. The role of Vitamin D3 metabolism in prostate cancer.
Lou YR; Qiao S; Talonpoika R; Syvälä H; Tuohimaa P
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):317-25. PubMed ID: 15663995
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of decreased Vitamin D 1alpha-hydroxylase activity in prostate cancer cells.
Ma JF; Nonn L; Campbell MJ; Hewison M; Feldman D; Peehl DM
Mol Cell Endocrinol; 2004 Jun; 221(1-2):67-74. PubMed ID: 15223133
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of vitamin D hydroxylase expression and activity in normal and malignant human prostate cells.
Khorchide M; Lechner D; Cross HS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):167-72. PubMed ID: 15860259
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.
Flanagan JN; Young MV; Persons KS; Wang L; Mathieu JS; Whitlatch LW; Holick MF; Chen TC
Anticancer Res; 2006; 26(4A):2567-72. PubMed ID: 16886665
[TBL] [Abstract][Full Text] [Related]
8. High fat diet-Induced obesity alters vitamin D metabolizing enzyme expression in mice.
Park JM; Park CY; Han SN
Biofactors; 2015 May; 41(3):175-82. PubMed ID: 25904060
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells.
Tokar EJ; Webber MM
Clin Exp Metastasis; 2005; 22(3):265-73. PubMed ID: 16158254
[TBL] [Abstract][Full Text] [Related]
10. Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells.
Farhan H; Wähälä K; Adlercreutz H; Cross HS
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Sep; 777(1-2):261-8. PubMed ID: 12270218
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney.
Akeno N; Matsunuma A; Maeda T; Kawane T; Horiuchi N
J Endocrinol; 2000 Mar; 164(3):339-48. PubMed ID: 10694374
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Vitamin D3 metabolism enhances VDR signalling in androgen-independent prostate cancer cells.
Yee SW; Campbell MJ; Simons C
J Steroid Biochem Mol Biol; 2006 Mar; 98(4-5):228-35. PubMed ID: 16483768
[TBL] [Abstract][Full Text] [Related]
13. Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.
Epstein MM; Andrén O; Kasperzyk JL; Shui IM; Penney KL; Fall K; Rider JR; Stampfer MJ; Andersson SO; Giovannucci E; Mucci LA
Cancer Causes Control; 2012 Aug; 23(8):1359-66. PubMed ID: 22710747
[TBL] [Abstract][Full Text] [Related]
14. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D status after a high dose of cholecalciferol in healthy and burn subjects.
Rousseau AF; Damas P; Ledoux D; Lukas P; Carlisi A; Le Goff C; Gadisseur R; Cavalier E
Burns; 2015 Aug; 41(5):1028-34. PubMed ID: 25529268
[TBL] [Abstract][Full Text] [Related]
16. Age-related alteration of vitamin D metabolism in response to low-phosphate diet in rats.
Chau TS; Lai WP; Cheung PY; Favus MJ; Wong MS
Br J Nutr; 2005 Mar; 93(3):299-307. PubMed ID: 15877868
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
18. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
19. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas.
Jones G; Ramshaw H; Zhang A; Cook R; Byford V; White J; Petkovich M
Endocrinology; 1999 Jul; 140(7):3303-10. PubMed ID: 10385427
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.
Miller GJ; Stapleton GE; Hedlund TE; Moffat KA
Clin Cancer Res; 1995 Sep; 1(9):997-1003. PubMed ID: 9816072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
